AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
25 Oct 2000 07:00 AM
RNS
3rd Qrt & 9 Mths Results-Pt.2
25 Oct 2000 07:00 AM
RNS
3rd Qrt & 9 Mths Results-Pt.1
17 Oct 2000 12:12 PM
RNS
Corporate Action
11 Oct 2000 12:28 PM
RNS
Result of EGM
09 Oct 2000 09:16 AM
RNS
Patent Dispute
21 Sep 2000 04:00 PM
RNS
Director Shareholding
18 Sep 2000 07:13 AM
RNS
Notice of EGM, etc.
08 Sep 2000 03:17 PM
RNS
Mylan Lab./Mylan Pharms.
04 Sep 2000 09:30 AM
RNS
Regulatory Approval
29 Aug 2000 10:01 AM
RNS
Statement re Asthma Treatment
25 Aug 2000 02:16 PM
RNS
Directors' Notification of Dealing in Shares
01 Aug 2000 08:09 AM
RNS
Dividend Notification
01 Aug 2000 07:13 AM
RNS
2nd Qtr & Interim Rslts-Pt3
01 Aug 2000 07:07 AM
RNS
2nd Qtr & Interim Rslts-Pt2
01 Aug 2000 07:05 AM
RNS
Nexium Launch Date, etc.
01 Aug 2000 07:05 AM
RNS
2nd Qtr & Interim Rslts-Pt1
26 Jul 2000 01:24 PM
RNS
Merger Update
12 Jul 2000 09:30 AM
RNS
Regulatory Approval
21 Jun 2000 08:40 AM
RNS
Lawsuit Against Lek Pharmaceutical & Chemical
19 Jun 2000 02:00 PM
RNS
Disposal
12 Jun 2000 07:00 AM
RNS
Purchase of Own Securities
08 Jun 2000 07:00 AM
RNS
Purchase of Own Securities
07 Jun 2000 07:00 AM
RNS
Purchase of Own Securities
06 Jun 2000 07:00 AM
RNS
Purchase of Own Securities
30 May 2000 12:08 PM
RNS
Result of AGM
25 May 2000 07:00 AM
RNS
Purchase of Own Securities
24 May 2000 07:00 AM
RNS
Purchase of Own Securities
19 May 2000 07:00 AM
RNS
Purchase of Own Securities
18 May 2000 04:00 PM
RNS
Directors' Notification of Dealing in Shares
17 May 2000 04:00 PM
RNS
Directors' Notification of Dealing in Shares
17 May 2000 02:56 PM
RNS
EU Competition Authority
15 May 2000 05:34 PM
RNS
Lawsuits
08 May 2000 04:00 PM
RNS
Directors' Notification of Dealing in Shares
03 May 2000 11:00 AM
RNS
1st Quarter Results - Part 2
03 May 2000 11:00 AM
RNS
1st Quarter Results - Part 1
12 Apr 2000 09:12 AM
RNS
Notice of EGM
21 Mar 2000 05:45 PM
RNS
Proposed Merger, etc
21 Mar 2000 03:52 PM
RNS
Re Federal Patent Court Appeal
17 Mar 2000 04:00 PM
RNS
Directors' Dealings
13 Mar 2000 07:02 AM
RNS
'Nexium' Receives Fast First Approval in Sweden
09 Mar 2000 12:29 PM
RNS
Omeprazole Substance Patent Upheld in Germany
08 Mar 2000 07:02 AM
RNS
Purchase of Own Securities
07 Mar 2000 09:18 AM
RNS
Purchase of Own Securities
06 Mar 2000 07:01 AM
RNS
Purchase of Own Securities
02 Mar 2000 07:01 AM
RNS
Purchase of Own Securities
01 Mar 2000 01:39 PM
RNS
Second Interim Dividend
01 Mar 2000 12:04 PM
RNS
Directors' Dealings
01 Mar 2000 07:04 AM
RNS
Purchase of Own Securities
29 Feb 2000 07:02 AM
RNS
Purchase of Own Securities
28 Feb 2000 09:30 AM
RNS
New Drug Application for Prostate Cancer Treatment
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100

Latest directors dealings